The clinical potential of microRNAs

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Budhu, Anuradha ^a   Ji, Junfang ^a   Wang, Xin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TUMOR MARKER;

BIOGENESIS; GENE OVEREXPRESSION; NEOPLASM; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RNA BINDING; RNA TRANSLATION; DRUG ANTAGONISM; GENETICS; HUMAN; PHYSIOLOGY;

HUMANS; MICRORNAS; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957311397     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-37     Document Type: Review

References (101)

1. MicroRNAs: genomics, biogenesis, mechanism, and function. DP Bartel, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438
2. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. CG Liu GA Calin B Meloon N Gamliel C Sevignani M Ferracin CD Dumitru M Shimizu S Zupo M Dono, et al. Proc Natl Acad Sci USA 2004 101 9740 9744 10.1073/pnas.0403293101 15210942
3. Real-time PCR quantification of precursor and mature microRNA. TD Schmittgen EJ Lee J Jiang A Sarkar L Yang TS Elton C Chen, Methods 2008 44 31 38 10.1016/j.ymeth.2007.09.006 18158130
4. A high-throughput method to monitor the expression of microRNA precursors. TD Schmittgen J Jiang Q Liu L Yang, Nucleic Acids Res 2004 32 43 10.1093/nar/gnh040 14985473
5. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. X Chen Y Ba L Ma X Cai Y Yin K Wang J Guo Y Zhang J Chen X Guo, et al. Cell Res 2008 18 997 1006 10.1038/cr.2008.282 18766170
6. Mechanisms of microRNA deregulation in human cancer. S Deng GA Calin CM Croce G Coukos L Zhang, Cell Cycle 2008 7 2643 2646 18719391
7. Role of microRNA and microRNA processing factors in development and disease. R Conrad M Barrier LP Ford, Birth Defects Res C Embryo Today 2006 78 107 117 10.1002/bdrc.20068 16847880
8. Regulation of microRNA processing in development, differentiation and cancer. TD Schmittgen, J Cell Mol Med 2008 12 1811 1819 18752632
9. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. JM Thomson M Newman JS Parker EM Morin-Kensicki T Wright SM Hammond, Genes Dev 2006 20 2202 2207 10.1101/gad.1444406 16882971
10. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. GA Calin M Ferracin A Cimmino G Di Leva M Shimizu SE Wojcik MV Iorio R Visone NI Sever M Fabbri, et al. N Engl J Med 2005 353 1793 1801 10.1056/NEJMoa050995 16251535
11. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. GA Calin CG Liu C Sevignani M Ferracin N Felli CD Dumitru M Shimizu A Cimmino S Zupo M Dono, et al. Proc Natl Acad Sci USA 2004 101 11755 11760 10.1073/pnas.0404432101 15284443
12. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. M Metzler M Wilda K Busch S Viehmann A Borkhardt, Genes Chromosomes Cancer 2004 39 167 169 10.1002/gcc.10316 14695998
13. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. J Takamizawa H Konishi K Yanagisawa S Tomida H Osada H Endoh T Harano Y Yatabe M Nagino Y Nimura, et al. Cancer Res 2004 64 3753 3756 10.1158/0008-5472.CAN-04-0637 15172979
14. Reduced accumulation of specific microRNAs in colorectal neoplasia. MZ Michael SM O'Connor NG Holst Pellekaan GP Young RJ James, Mol Cancer Res 2003 1 882 891 14573789
15. MicroRNA gene expression deregulation in human breast cancer. MV Iorio M Ferracin CG Liu A Veronese R Spizzo S Sabbioni E Magri M Pedriali M Fabbri M Campiglio, et al. Cancer Res 2005 65 7065 7070 10.1158/0008-5472.CAN-05-1783 16103053
16. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. GA Calin CD Dumitru M Shimizu R Bichi S Zupo E Noch H Aldler S Rattan M Keating K Rai, et al. Proc Natl Acad Sci USA 2002 99 15524 15529 10.1073/pnas.242606799 12434020
17. Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. T Sonoki E Iwanaga H Mitsuya N Asou, Leukemia 2005 19 2009 2010 10.1038/sj.leu.2403938 16151463
18. miR-15 and miR-16 induce apoptosis by targeting BCL2. A Cimmino GA Calin M Fabbri MV Iorio M Ferracin M Shimizu SE Wojcik RI Aqeilan S Zupo M Dono, et al. Proc Natl Acad Sci USA 2005 102 13944 13949 10.1073/pnas.0506654102 16166262
19. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. JA Chan AM Krichevsky KS Kosik, Cancer Res 2005 65 6029 6033 10.1158/0008-5472.CAN- 05-0137 16024602
20. MicroRNA expression profiles classify human cancers. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando, et al. Nature 2005 435 834 838 10.1038/nature03702 15944708
21. A microRNA expression signature of human solid tumors defines cancer gene targets. S Volinia GA Calin CG Liu S Ambs A Cimmino F Petrocca R Visone M Iorio C Roldo M Ferracin, et al. Proc Natl Acad Sci USA 2006 103 2257 2261 10.1073/pnas.0510565103 16461460
22. RAS is regulated by the let-7 microRNA family. SM Johnson H Grosshans J Shingara M Byrom R Jarvis A Cheng E Labourier KL Reinert D Brown FJ Slack, Cell 2005 120 635 647 10.1016/j.cell.2005.01.014 15766527
23. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Y Hayashita H Osada Y Tatematsu H Yamada K Yanagisawa S Tomida Y Yatabe K Kawahara Y Sekido T Takahashi, Cancer Res 2005 65 9628 9632 10.1158/0008-5472.CAN-05-2352 16266980
24. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. F Meng R Henson M Lang H Wehbe S Maheshwari JT Mendell J Jiang TD Schmittgen T Patel, Gastroenterology 2006 130 2113 2129 10.1053/j.gastro.2006.02.057 16762633
25. A microRNA expression signature of human solid tumors defines cancer gene targets. S Volinia GA Calin CG Liu S Ambs A Cimmino F Petrocca R Visone M Iorio C Roldo M Ferracin, et al. Proc Natl Acad Sci USA 2006 103 2257 2261 10.1073/pnas.0510565103 16461460
26. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. V Ambros, Cell 2003 113 673 676 10.1016/S0092-8674(03)00428-8 12809598
27. Modulation of microRNA activity in human cancer: a new paradigm for cancer gene therapy? AW Tong J Nemunaitis, Cancer Gene Ther 2008 15 341 355 10.1038/cgt.2008.8 18369380
28. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. TC Chang EA Wentzel OA Kent K Ramachandran M Mullendore KH Lee G Feldmann M Yamakuchi M Ferlito CJ Lowenstein, et al. Mol Cell 2007 26 745 752 10.1016/j.molcel.2007.05.010 17540599
29. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. T Chiyomaru H Enokida S Tatarano K Kawahara Y Uchida K Nishiyama L Fujimura N Kikkawa N Seki M Nakagawa, Br J Cancer 2010 102 883 891 10.1038/sj.bjc.6605570 20160723
30. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. Y Lee X Yang Y Huang H Fan Q Zhang Y Wu J Li R Hasina C Cheng MW Lingen, et al. PLoS Comput Biol 2010 6 1000730 10.1371/journal.pcbi.1000730 20369013
31. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. L Gramantieri M Ferracin F Fornari A Veronese S Sabbioni CG Liu GA Calin C Giovannini E Ferrazzi GL Grazi, et al. Cancer Res 2007 67 6092 6099 10.1158/0008-5472.CAN-06-4607 17616664
32. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. L Gramantieri F Fornari M Ferracin A Veronese S Sabbioni GA Calin GL Grazi CM Croce L Bolondi M Negrini, Clin Cancer Res 2009 15 5073 5081 10.1158/1078-0432.CCR-09-0092 19671867
33. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. B Song C Wang J Liu X Wang L Lv L Wei L Xie Y Zheng X Song, J Exp Clin Cancer Res 2010 29 29 10.1186/1756-9966-29- 29 20346171
34. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. E Favaro A Ramachandran R McCormick H Gee C Blancher M Crosby C Devlin C Blick F Buffa JL Li, et al. PLoS ONE 2010 5 10345 10.1371/journal.pone.0010345 20436681
35. The Role of Hypoxia Regulated microRNAs in Cancer. R McCormick FM Buffa J Ragoussis AL Harris, Curr Top Microbiol Immunol 2010 20549470
36. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. S Cascio A D'Andrea R Ferla E Surmacz E Gulotta V Amodeo V Bazan N Gebbia A Russo, J Cell Physiol 2010 224 242 249 20232316
37. MicroRNA signatures in human cancers. GA Calin CM Croce, Nat Rev Cancer 2006 6 857 866 10.1038/nrc1997 17060945
38. microRNAs in cancer: approaches, aetiology, diagnostics and therapy. C Blenkiron EA Miska, Hum Mol Genet 2007 16 Spec No 1 106 R113 10.1093/hmg/ddm056 17613543
39. Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma. Y Hoshida A Villanueva M Kobayashi J Peix DY Chiang A Camargo S Gupta J Moore MJ Wrobel J Lerner, et al. N Engl J Med 2008 18923165
40. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. N Yanaihara N Caplen E Bowman M Seike K Kumamoto M Yi RM Stephens A Okamoto J Yokota T Tanaka, et al. Cancer Cell 2006 9 189 198 10.1016/j.ccr.2006.01.025 16530703
41. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. AJ Schetter SY Leung JJ Sohn KA Zanetti ED Bowman N Yanaihara ST Yuen TL Chan DL Kwong GK Au, et al. JAMA 2008 299 425 436 10.1001/jama.299.4.425 18230780
42. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. R Garzon S Volinia CG Liu C Fernandez-Cymering T Palumbo F Pichiorri M Fabbri K Coombes H Alder T Nakamura, et al. Blood 2008 111 3183 3189 10.1182/blood-2007-07-098749 18187662
43. New kids on the block: Diagnostic and prognostic microRNAs in hepatocellular carcinoma. J Ji XW Wang, Cancer Biol Ther 2009 8
44. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. J Jiang Y Gusev I Aderca TA Mettler DM Nagorney DJ Brackett LR Roberts TD Schmittgen, Clin Cancer Res 2008 14 419 427 10.1158/1078-0432.CCR-07-0523 18223217
45. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. GE Chung JH Yoon SJ Myung JH Lee SH Lee SM Lee SJ Kim SY Hwang HS Lee CY Kim, Oncol Rep 2010 23 113 119 10.3892/or-00000682 19956871
46. Identification of metastasis-related microRNAs in hepatocellular carcinoma. A Budhu HL Jia M Forgues CG Liu D Goldstein A Lam KA Zanetti QH Ye LX Qin CM Croce, et al. Hepatology 2008 47 897 907 10.1002/hep.22160 18176954
47. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. C Coulouarn VM Factor JB Andersen ME Durkin SS Thorgeirsson, Oncogene 2009 28 3526 3536 10.1038/onc.2009.211 19617899
48. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Q Huang K Gumireddy M Schrier C le Sage R Nagel S Nair DA Egan A Li G Huang AJ Klein-Szanto, et al. Nat Cell Biol 2008 10 202 210 10.1038/ncb1681 18193036
49. Breast cancer metastasis: a microRNA story. M Negrini GA Calin, Breast Cancer Res 2008 10 203 10.1186/bcr1867 18373886
50. Endogenous human microRNAs that suppress breast cancer metastasis. SF Tavazoie C Alarcon T Oskarsson D Padua Q Wang PD Bos WL Gerald J Massague, Nature 2008 451 147 152 10.1038/nature06487 18185580
51. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. YS Huang Y Dai XF Yu SY Bao YB Yin M Tang CX Hu, J Gastroenterol Hepatol 2008 23 87 94 10.1111/j.1440-1746. 2007.05223.x 18171346
52. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Y Murakami T Yasuda K Saigo T Urashima H Toyoda T Okanoue K Shimotohno, Oncogene 2006 25 2537 2545 10.1038/sj.onc.1209283 16331254
53. MicroRNA expression, survival, and response to interferon in liver cancer. J Ji J Shi A Budhu Z Yu M Forgues S Roessler S Ambs Y Chen PS Meltzer CM Croce, et al. N Engl J Med 2009 361 1437 1447 10.1056/NEJMoa0901282 19812400
54. Anti-microRNA oligonucleotides (AMOs): ammunition to target microRNAs implicated in human disease? J Weiler J Hunziker J Hall, Gene Ther 2006 13 496 502 10.1038/sj.gt.3302654 16195701
55. 2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. BF Baker SS Lot TP Condon S Cheng-Flournoy EA Lesnik HM Sasmor CF Bennett, J Biol Chem 1997 272 11994 12000 10.1074/jbc.272.18.11994 9115264
56. miR-21-mediated tumor growth. ML Si S Zhu H Wu Z Lu F Wu YY Mo, Oncogene 2007 26 2799 2803 10.1038/sj.onc.1210083 17072344
57. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. C Esau S Davis SF Murray XX Yu SK Pandey M Pear L Watts SL Booten M Graham R McKay, et al. Cell Metab 2006 3 87 98 10.1016/j.cmet.2006.01.005 16459310
58. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. J Stenvang AN Silahtaroglu M Lindow J Elmen S Kauppinen, Semin Cancer Biol 2008 18 89 102 10.1016/j.semcancer.2008.01.004 18295505
59. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. MF Corsten R Miranda R Kasmieh AM Krichevsky R Weissleder K Shah, Cancer Res 2007 67 8994 9000 10.1158/0008-5472.CAN-07-1045 17908999
60. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. MS Ebert JR Neilson PA Sharp, Nat Methods 2007 4 721 726 10.1038/nmeth1079 17694064
61. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Xiao B Yang H Lin Y Lu X Luo Z Wang, J Cell Physiol 2007 212 285 292 10.1002/jcp.21062 17516552
62. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. WY Choi AJ Giraldez AF Schier, Science 2007 318 271 274 10.1126/science.1147535 17761850
63. Small-molecule inhibitors of microrna miR-21 function. K Gumireddy DD Young X Xiong JB Hogenesch Q Huang A Deiters, Angew Chem Int Ed Engl 2008 47 7482 7484 10.1002/anie.200801555 18712719
64. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. KH Chung CC Hart S Al-Bassam A Avery J Taylor PD Patel AB Vojtek DL Turner, Nucleic Acids Res 2006 34 53 10.1093/nar/gkl143 16614444
65. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. F Stegmeier G Hu RJ Rickles GJ Hannon SJ Elledge, Proc Natl Acad Sci USA 2005 102 13212 13217 10.1073/pnas.0506306102 16141338
66. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. Q Ji X Hao Y Meng M Zhang J Desano D Fan L Xu, BMC Cancer 2008 8 266 10.1186/1471-2407-8-266 18803879
67. let-7 regulates self renewal and tumorigenicity of breast cancer cells. F Yu H Yao P Zhu X Zhang Q Pan C Gong Y Huang X Hu F Su J Lieberman, et al. Cell 2007 131 1109 1123 10.1016/j.cell.2007.10.054 18083101
68. miR-15 and miR-16 induce apoptosis by targeting BCL2. A Cimmino GA Calin M Fabbri MV Iorio M Ferracin M Shimizu SE Wojcik RI Aqeilan S Zupo M Dono, et al. Proc Natl Acad Sci USA 2005 102 13944 13949 10.1073/pnas.0506654102 16166262
69. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. D Bonci V Coppola M Musumeci A Addario R Giuffrida L Memeo L D'Urso A Pagliuca M Biffoni C Labbaye, et al. Nat Med 2008 14 1271 1277 10.1038/nm.1880 18931683
70. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. J Kota RR Chivukula KA O'donnell EA Wentzel CL Montgomery HW Hwang TC Chang P Vivekanandan M Torbenson KR Clark, et al. Cell 2009 137 1005 1017 10.1016/j.cell.2009.04.021 19524505
71. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. CN Landen Jr A Chavez-Reyes C Bucana R Schmandt MT Deavers G Lopez-Berestein AK Sood, Cancer Res 2005 65 6910 6918 10.1158/0008-5472.CAN-05-0530 16061675
72. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. WM Merritt YG Lin WA Spannuth MS Fletcher AA Kamat LY Han CN Landen N Jennings GK De RR Langley, et al. J Natl Cancer Inst 2008 100 359 372 10.1093/jnci/djn024 18314475
73. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. A Akinc A Zumbuehl M Goldberg ES Leshchiner V Busini N Hossain SA Bacallado DN Nguyen J Fuller R Alvarez, et al. Nat Biotechnol 2008 26 561 569 10.1038/nbt1402 18438401
74. Designing small multiple-target artificial RNAs. GV De M Caron N Scott C Menard MF Gaumont-Leclerc P Chartrand F Major G Ferbeyre, Nucleic Acids Res 2010
75. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. S Zhu H Wu F Wu D Nie S Sheng YY Mo, Cell Res 2008 18 350 359 10.1038/cr.2008.24 18270520
76. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. AJ Lowery N Miller RE McNeill MJ Kerin, Clin Cancer Res 2008 14 360 365 10.1158/1078-0432.CCR-07-0992 18223209
77. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. E Bandres E Cubedo X Agirre R Malumbres R Zarate N Ramirez A Abajo A Navarro I Moreno M Monzo, et al. Mol Cancer 2006 5 29 10.1186/1476-4598-5-29 16854228
78. The colorectal microRNAome. JM Cummins Y He RJ Leary R Pagliarini LA Diaz Jr T Sjoblom O Barad Z Bentwich AE Szafranska E Labourier, et al. Proc Natl Acad Sci USA 2006 103 3687 3692 10.1073/pnas.0511155103 16505370
79. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. H Tazawa N Tsuchiya M Izumiya H Nakagama, Proc Natl Acad Sci USA 2007 104 15472 15477 10.1073/pnas.0707351104 17875987
80. SnapShot: MicroRNAs in Cancer. R Spizzo MS Nicoloso CM Croce GA Calin, Cell 2009 137 586 10.1016/j.cell.2009.04.040 19410551
81. MicroRNA and lung cancer. M Eder M Scherr, N Engl J Med 2005 352 2446 2448 10.1056/NEJMcibr051201 15944431
82. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. M Bloomston WL Frankel F Petrocca S Volinia H Alder JP Hagan CG Liu D Bhatt C Taccioli CM Croce, JAMA 2007 297 1901 1908 10.1001/jama.297.17.1901 17473300
83. Expression profiling identifies microRNA signature in pancreatic cancer. EJ Lee Y Gusev J Jiang GJ Nuovo MR Lerner WL Frankel DL Morgan RG Postier DJ Brackett TD Schmittgen, Int J Cancer 2007 120 1046 1054 10.1002/ijc.22394 17149698 (Pubitemid 46214304)
84. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. C Roldo E Missiaglia JP Hagan M Falconi P Capelli S Bersani GA Calin S Volinia CG Liu A Scarpa, et al. J Clin Oncol 2006 24 4677 4684 10.1200/JCO.2005.05.5194 16966691
85. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. MD Mattie CC Benz J Bowers K Sensinger L Wong GK Scott V Fedele D Ginzinger R Getts C Haqq, Mol Cancer 2006 5 24 10.1186/1476-4598-5-24 16784538
86. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. S Ambs RL Prueitt M Yi RS Hudson TM Howe F Petrocca TA Wallace CG Liu S Volinia GA Calin, et al. Cancer Res 2008 68 6162 6170 10.1158/0008-5472.CAN-08-0144 18676839
87. MicroRNA signatures in human ovarian cancer. MV Iorio R Visone LG Di V Donati F Petrocca P Casalini C Taccioli S Volinia CG Liu H Alder, et al. Cancer Res 2007 67 8699 8707 10.1158/0008-5472.CAN-07-1936 17875710
88. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. DD Taylor C Gercel-Taylor, Gynecol Oncol 2008 110 13 21 10.1016/j.ygyno.2008.04.033 18589210
89. miR-221 overexpression contributes to liver tumorigenesis. P Pineau S Volinia K McJunkin A Marchio C Battiston B Terris V Mazzaferro SW Lowe CM Croce A Dejean, Proc Natl Acad Sci USA 2010 107 264 269 10.1073/pnas.0907904107 20018759
90. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Ji L Zhao A Budhu M Forgues HL Jia LX Qin QH Ye J Yu X Shi ZY Tang, et al. J Hepatol 2010 52 690 697 10.1016/j.jhep.2009.12.025 20338660
91. The role of microRNA genes in papillary thyroid carcinoma. H He K Jazdzewski W Li S Liyanarachchi R Nagy S Volinia GA Calin CG Liu K Franssila S Suster, et al. Proc Natl Acad Sci USA 2005 102 19075 19080 10.1073/pnas. 0509603102 16365291
92. MicroRNA expression profiles in thyroid tumors. MN Nikiforova SI Chiosea YE Nikiforov, Endocr Pathol 2009 20 85 91 10.1007/s12022-009-9069-z 19352602
93. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. R Visone P Pallante A Vecchione R Cirombella M Ferracin A Ferraro S Volinia S Coluzzi V Leone E Borbone, et al. Oncogene 2007 26 7590 7595 10.1038/sj.onc.1210564 17563749
94. Silencing of microRNAs in vivo with 'antagomirs'. J Krutzfeldt N Rajewsky R Braich KG Rajeev T Tuschl M Manoharan M Stoffel, Nature 2005 438 685 689 10.1038/nature04303 16258535
95. Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation. MK Bijsterbosch ET Rump RL De Vrueh R Dorland VR van KL Tivel EA Biessen TJ Van Berkel M Manoharan, Nucleic Acids Res 2000 28 2717 2725 10.1093/nar/28.14.2717 10908328
96. bis-Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides are highly selectively taken up by the liver. MK Bijsterbosch M Manoharan R Dorland VR van EA Biessen TJ Van Berkel, J Pharmacol Exp Ther 2002 302 619 626 10.1124/jpet.302.2.619 12130724
97. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. H Wu WF Lima H Zhang A Fan H Sun ST Crooke, J Biol Chem 2004 279 17181 17189 10.1074/jbc.M311683200 14960586
98. Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. SM Cerritelli EG Frolova C Feng A Grinberg PE Love RJ Crouch, Mol Cell 2003 11 807 815 10.1016/S1097-2765(03)00088-1 12667461
99. LNA-mediated microRNA silencing in non-human primates. J Elmen M Lindow S Schutz M Lawrence A Petri S Obad M Lindholm M Hedtjarn HF Hansen U Berger, et al. Nature 2008 18368051
100. Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells. N Tsuda S Ishiyama Y Li CG Ioannides JL Abbruzzese DZ Chang, Clin Cancer Res 2006 12 6557 6564 10.1158/1078-0432.CCR-06-0588 17085671
101. Synthetic microRNA targeting glioma-associated antigen-1 protein. N Tsuda T Mine CG Ioannides DZ Chang, Methods Mol Biol 2009 487 435 449 full-text 19301660